Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/09/021122
CTRI/2019/09/021122
Completed
未知

ââ?¬Å?A Study to Evaluate the prevalence, Epidemiological Determinants, Co Morbidity , Complications And Community based prevention initiatives of type 2 diabetes mellitus at selected Rural And Urban South Indian population ââ?¬?

RojaVanam Trust0 sites256 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
RojaVanam Trust
Enrollment
256
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
RojaVanam Trust

Eligibility Criteria

Inclusion Criteria

  • •All adults (both men \& women) aged Between 20 years and 75 Years.
  • •Usual resident of the selected locality.
  • •Willing to provide written consent to participate in the study.
  • •Mentally stable to provide the details required for the study.

Exclusion Criteria

  • •Those who are seriously ill at the time Data collection .
  • •Not willing to provide written consent for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Epidemiological Study to Evaluate the Prevalence and Progression of Diabetic Macular Ischemia in Patients with Diabetic Retinopathy Treated with Panretinal Photocoagulatio
JPRN-UMIN000042801Boehringer Ingelheim International GmbH539
Recruiting
Not Applicable
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.Health Condition 1: null- Non Small Cell Lung Cancer
CTRI/2013/10/004077Roche Products India Pvt Ltd250
Recruiting
Not Applicable
RETROSPECTIVE OBSERVATIONAL STUDY OF BRAF AND PIK3CA MUTATION IN INDIAN PATIENTS WITH COLORECTAL CANCERâ??Health Condition 1: null- Colorectal CancerHealth Condition 2: C189- Malignant neoplasm of colon, unspecified
CTRI/2016/06/006989Tata Memorial Hospital
Recruiting
Not Applicable
Epidemiological Study to Determine the Prevalence of ctDNA Positivity in Participants With Stage II (High Risk) or Stage III CRC After Surgery With Curative (R0) Intent and Subsequent Adjuvant Chemotherapy With Monitoring of ctDNA During Clinical Follow-upColorectal Cancer Stage IIColorectal Cancer Stage III
DRKS00025104BioNTech SE1,500
Completed
Not Applicable
Implication of finding various Antibiotics Resistance bacteria on patients body suface at the time of Admission to Intensive care Units
CTRI/2012/12/003217MedantaThe Medicity500